Skip to content
Search

Latest Stories

Lord Darzi's NHS investigation: IRP submits evidence, highlights shift in reconfiguration trends

Lord Darzi's NHS investigation: IRP submits evidence, highlights shift in reconfiguration trends

Professor Sir Norman Williams, Chair of the IRP, informs Lord Darzi's independent investigation that recent NHS reconfigurations are driven by operational challenges rather than a focus on improving clinical outcomes

The Independent Reconfiguration Panel (IRP) has submitted evidence to Lord Darzi's independent investigation into NHS performance.


The IRP, accountable to the Secretary of State, primarily advises ministers on reconfigurations and changes to NHS services in England. Additionally, they offer informal advice to any parties involved in NHS service changes to help improve policy and practice.

Lord Darzi's 2008 report, Leading Local Change, part of the wider NHS Next Stage Review, stressed that NHS reconfigurations should be clinically driven, locally led, and focused on benefiting patients.

In a letter to Lord Darzi, Professor Sir Norman Williams, Chair of the IRP, acknowledged the NHS has significantly improved in this area, particularly in its approach to involving the public and patients, including using the regional Clinical Senates to support and assure local work.

However, in recent times, there has been a change in the trend due to the significant performance challenges faced by the NHS.

The IRP has observed that “rather than service change being driven by an ambition to improve clinical outcomes, the trend has often been for reconfigurations to emerge from operational necessity such as a lack of NHS staffing to sustain services, as well as the poor condition of NHS estates.”

This issue is particularly evident in the community hospitals, Professor Williams stated in the letter.

Over the past 20 years, the most common type of NHS reconfiguration referred to the IRP has been the major reorganisation of acute hospital care, such as the centralisation of emergency and elective care on separate ‘hot’ and ‘cold’ hospital sites.

Professor Williams noted that these proposals frequently result in the 'downgrade' of a hospital site, replacing the emergency department with an urgent treatment centre, which understandably becomes an emotional and contentious issue for the local community.

The IRP is also concerned about services that were temporarily closed or reconfigured due to staffing issues during the Covid-19 pandemic but remain so years later.

Professor Williams pointed out that these 'temporary reconfigurations' are common in urgent treatment centres and freestanding midwifery-led birth units, restricting access to care and raising concerns about their long-term sustainability.

“The continuing uncertainty around the future of these services is unfair to patients and the NHS staff who work in them,” he said.

Professor Williams stressed the importance of NHS integrated care boards regularly reviewing these ongoing temporary changes and developing long-term plans in collaboration with local system partners and the public.

The IRP has welcomed the new powers introduced via the Health and Care Act 2022, which allow the Secretary of State to intervene in NHS reconfigurations by 'calling in' proposals for a decision and acting as the final arbiter.

“The new legislation presents an opportunity for ministers to take decisions on NHS reconfigurations in a timely manner and ensure progress is made when options for local resolution have been exhausted,” Professor Williams said.

He emphasised that a decision by the Secretary of State to 'call in' a proposal should be seen as a neutral act, allowing ministers to examine concerns raised by stakeholders using a fair process.

Additionally, Professor Williams believes there is potential to streamline the approval process for major capital schemes involving the reconfiguration of NHS services.

The IRP also stresses that NHS reconfiguration proposals should include a meaningful impact assessment that addresses both health and healthcare inequalities.

“Wider factors such as socio-economic deprivation, healthy life expectancy and changes in population demographics can also often be overlooked in NHS reconfiguration planning and need to be considered using a system wide approach,” Professor Williams suggested.

In July, Health Secretary, Wes Streeting, ordered this independent investigation aimed at uncovering the “hard truths” about the “broken” NHS.

The findings from this investigation, which is expected to be completed by September, will provide the basis for the government’s 10-year plan to reform the NHS.

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less